Analyst Activity – Needham & Company LLC Reiterates Buy on Ionis Pharmaceuticals (NASDAQ:IONS)

ME Staff
-
0

Analyst Ratings For Ionis Pharmaceuticals (NASDAQ:IONS)

Today, Needham & Company LLC reiterated its Buy rating on Ionis Pharmaceuticals (NASDAQ:IONS) with a price target of $64.00.

There are 2 sell ratings, 6 hold ratings, 6 buy ratings on the stock.

The current consensus rating on Ionis Pharmaceuticals (NASDAQ:IONS) is Hold (Score: 2.29) with a consensus target price of $49.62 per share, a potential 18.90% downside.

Some recent analyst ratings include

  • 10/17/2017-Needham & Company LLC Reiterated Rating of Buy.
  • 10/13/2017-Stifel Nicolaus Reiterated Rating of Hold.
  • 10/6/2017-Goldman Sachs Group, Inc. (The) Reiterated Rating of Sell .
  • 10/2/2017-BMO Capital Markets Reiterated Rating of Outperform.
  • 8/16/2017-Evercore ISI initiated coverage with a Outperform rating.
  • 8/14/2017-Laidlaw Reiterated Rating of Buy.

Recent Insider Trading Activity For Ionis Pharmaceuticals (NASDAQ:IONS)
Ionis Pharmaceuticals (NASDAQ:IONS) has insider ownership of 2.13% and institutional ownership of 89.24%.

  • On 10/5/2017 Patrick R O’neil, SVP, sold 1,000 with an average share price of $55.00 per share and the total transaction amounting to $55,000.00. View SEC Filing
  • On 10/4/2017 Stanley T Crooke, Chairman, sold 27,500 with an average share price of $52.89 per share and the total transaction amounting to $1,454,475.00. View SEC Filing
  • On 10/2/2017 Stanley T Crooke, CEO, sold 15,000 with an average share price of $52.00 per share and the total transaction amounting to $780,000.00. View SEC Filing
  • On 9/6/2017 Patrick R O’neil, SVP, sold 1,000 with an average share price of $55.00 per share and the total transaction amounting to $55,000.00. View SEC Filing
  • On 7/24/2017 C Frank Bennett, SVP, sold 10,000 with an average share price of $59.29 per share and the total transaction amounting to $592,900.00. View SEC Filing
  • On 7/20/2017 Stanley T Crooke, Chairman, sold 11,000 with an average share price of $55.35 per share and the total transaction amounting to $608,850.00. View SEC Filing
  • On 7/19/2017 Ionis Pharmaceuticals Inc, Major Shareholder, bought 3,125,000 with an average share price of $8.00 per share and the total transaction amounting to $25,000,000.00. View SEC Filing

Recent Trading Activity for Ionis Pharmaceuticals (NASDAQ:IONS)
Shares of Ionis Pharmaceuticals closed the previous trading session at with shares trading hands.